169 related articles for article (PubMed ID: 28872546)
1. 68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Epithelioid Hemangioendothelioma: Comparison With 18F-FDG.
Derlin T; Hueper K; Soudah B
Clin Nucl Med; 2017 Nov; 42(11):e478-e479. PubMed ID: 28872546
[TBL] [Abstract][Full Text] [Related]
2. 68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Metastasizing Chordoma: Comparison With 18F-FDG.
Derlin T; Sohns JM; Hueper K
Clin Nucl Med; 2017 Apr; 42(4):e210-e211. PubMed ID: 28166150
[TBL] [Abstract][Full Text] [Related]
3. 68Ga-DOTA-TATE PET/CT for Molecular Imaging of Somatostatin Receptor Expression in Extra-adrenal Paraganglioma in a Case of Complete Carney Triad.
Derlin T; Hartung D; Hueper K
Clin Nucl Med; 2017 Dec; 42(12):e527-e528. PubMed ID: 29076898
[TBL] [Abstract][Full Text] [Related]
4. (68)Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma.
Khor LK; Loi HY; Sinha AK; Tong KT; Goh BC; Loh KS; Lu SJ
Head Neck; 2016 Apr; 38(4):E76-80. PubMed ID: 26275126
[TBL] [Abstract][Full Text] [Related]
5. Complete metabolic response to therapy of hepatic epithelioid hemangioendothelioma evaluated with 18F-fluorodeoxyglucose positron emission tomography/contrast-enhanced computed tomography: A CARE case report.
Giancipoli RG; Monti S; Basturk O; Klimstra D; Keohan ML; Schillaci O; Corrias G; Sawan P; Mannelli L
Medicine (Baltimore); 2018 Oct; 97(42):e12795. PubMed ID: 30334971
[TBL] [Abstract][Full Text] [Related]
6. FDG PET/CT of Mediastinal Epithelioid Hemangioendothelioma.
Hod N; Anconina R; Levin D; Delgado B; Dudnik J; Lantsberg S
Clin Nucl Med; 2019 Sep; 44(9):e540-e543. PubMed ID: 31283613
[TBL] [Abstract][Full Text] [Related]
7. Primary splenic epithelioid hemangioendothelioma with diffuse metastases revealed by FDG PET/CT imaging: A case report.
Li X; Ma X; Hao J; Dong C; Wang Y
Medicine (Baltimore); 2021 Apr; 100(13):e25065. PubMed ID: 33787588
[TBL] [Abstract][Full Text] [Related]
8. Malignant epithelioid hemangioendothelioma of the lower extremity: staging with F-18 FDG PET/CT.
Makis W; Ciarallo A; Nahal A; Derbekyan V
Clin Nucl Med; 2011 Jul; 36(7):590-2. PubMed ID: 21637069
[TBL] [Abstract][Full Text] [Related]
9. 68 Ga-FAPI Versus 18 F-FDG PET/CT in the Evaluation of Epithelioid Hemangioendothelioma of Bone.
Xu W; Cai J; Meng T; Pang Y; Chen H
Clin Nucl Med; 2023 May; 48(5):460-462. PubMed ID: 36800246
[TBL] [Abstract][Full Text] [Related]
10. The role of 68Ga-DOTA-TATE PET/CT scanning in the evaluation of patients with multiple myeloma: preliminary results.
Sonmezoglu K; Vatankulu B; Elverdi T; Akyel R; Erkan ME; Halac M; Ocak M; Demirci E; Aydin Y
Nucl Med Commun; 2017 Jan; 38(1):76-83. PubMed ID: 27775994
[TBL] [Abstract][Full Text] [Related]
11. Combined imaging with 68Ga-DOTA-TATE and 18F-FDG PET/CT on the basis of volumetric parameters in neuroendocrine tumors.
Abdulrezzak U; Kurt YK; Kula M; Tutus A
Nucl Med Commun; 2016 Aug; 37(8):874-81. PubMed ID: 27096719
[TBL] [Abstract][Full Text] [Related]
12. Direct comparison of (68)Ga-DOTA-TOC and (18)F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle.
Nilica B; Waitz D; Stevanovic V; Uprimny C; Kendler D; Buxbaum S; Warwitz B; Gerardo L; Henninger B; Virgolini I; Rodrigues M
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1585-92. PubMed ID: 26922350
[TBL] [Abstract][Full Text] [Related]
13. 18 F-FDG PET/CT Imaging of Prostatic Epithelioid Hemangioendothelioma.
Deng Y; Deng Y; He L; Zhang W; Lei X
Clin Nucl Med; 2024 Feb; 49(2):191-192. PubMed ID: 38049968
[TBL] [Abstract][Full Text] [Related]
14. FDG-PET/CT in the evaluation of epithelioid hemangioendothelioma of the liver: the role of dual-time-point imaging. A case presentation and review of the literature.
Kitapci MT; Akkaş BE; Gullu I; Sokmensuer C
Ann Nucl Med; 2010 Aug; 24(7):549-53. PubMed ID: 20414751
[TBL] [Abstract][Full Text] [Related]
15.
El-Maouche D; Sadowski SM; Papadakis GZ; Guthrie L; Cottle-Delisle C; Merkel R; Millo C; Chen CC; Kebebew E; Collins MT
J Clin Endocrinol Metab; 2016 Oct; 101(10):3575-3581. PubMed ID: 27533306
[TBL] [Abstract][Full Text] [Related]
16. Dual-tracer PET/CT imaging to determine tumor heterogeneity in a patient with metastatic ACTH-secreting neuroendocrine neoplasm: A case report and literature review.
Ryzhkova D; Mitrofanova L; Tsoy U; Grineva E; Schlyakhto E
Front Endocrinol (Lausanne); 2022; 13():958442. PubMed ID: 36133304
[TBL] [Abstract][Full Text] [Related]
17. Mediastinal Epithelioid Hemangioendothelioma Revealed on 68Ga-DOTATATE PET/CT.
Long Y; Shao F; Lan X
Clin Nucl Med; 2020 May; 45(5):414-416. PubMed ID: 32209882
[TBL] [Abstract][Full Text] [Related]
18. Metastatic Medullary Thyroid Cancer: The Role of 68Gallium-DOTA-Somatostatin Analogue PET/CT and Peptide Receptor Radionuclide Therapy.
Hayes AR; Crawford A; Al Riyami K; Tang C; Bomanji J; Baldeweg SE; Wild D; Morganstein D; Harry A; Grozinsky-Glasberg S; Oleinikov K; Khoo B; Caplin ME; Nicolas GP; Grossman AB
J Clin Endocrinol Metab; 2021 Nov; 106(12):e4903-e4916. PubMed ID: 34379772
[TBL] [Abstract][Full Text] [Related]
19. Multifocal epithelioid hemangioendothelioma of the lower limbs detected by 18F-FDG PET/MRI.
Treglia G; Ceriani L; Paone G; Rusca T; Bongiovanni M; Giovanella L
Clin Nucl Med; 2014 Sep; 39(9):e402-4. PubMed ID: 24445271
[TBL] [Abstract][Full Text] [Related]
20. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
Sampathirao N; Basu S
J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
